Livforsakringsbolaget Skandia’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.6M Sell
241,103
-50,247
-17% -$2.16M 0.6% 41
2025
Q4
$19.6M Buy
291,350
+188,700
+184% +$7.81M 0.76% 25
2025
Q3
$6.05M Buy
102,650
+24,550
+31% +$987K 0.24% 88
2025
Q2
$3.44M Buy
+78,100
New +$3.12M 0.15% 115

Other funds holding EXEL

Livforsakringsbolaget Skandia's EXEL Position: Q1 2026 in Review

Livforsakringsbolaget Skandia reduced its Exelixis (EXEL) stake by 17% in Q1 2026, selling an estimated $2.16M and leaving 241,103 shares worth $15.6M. The position accounts for 0.6% of the portfolio, ranked #41.

Livforsakringsbolaget Skandia first reported a position in EXEL in Q2 2025 and has held it in 4 quarters since. The position peaked at $19.6M in Q4 2025. 697 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Livforsakringsbolaget Skandia held 241,103 shares of Exelixis worth $15.6M as of Q1 2026.
  • Livforsakringsbolaget Skandia sold 50,247 Exelixis shares in Q1 2026, an estimated $2.16M.
  • Exelixis made up 0.6% of Livforsakringsbolaget Skandia's portfolio in Q1 2026, its #41 holding.
  • Livforsakringsbolaget Skandia first reported a position in Exelixis in Q2 2025 and has held it in 4 quarters since.
  • Livforsakringsbolaget Skandia's Exelixis position peaked at $19.6M in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Livforsakringsbolaget Skandia's 13F filing for Q1 2026, filed 5 May 2026.